What Happened to Claritev?
Ticker: CTEVSPAC Year: 2020Merger: 2020
Return
+54.5%
Current Price
$8
Peak Price
$517.2
Trust Size
$4.9B
Summary
Claritev (formerly MultiPlan) is a healthcare cost management company that provides data analytics-driven solutions to help payers manage the cost of healthcare. It went public via SPAC merger with Churchill Capital Corp VII in 2020 in a $5.7 billion deal. The company generates nearly $1 billion in annual revenue.
What Happened
Churchill Capital Corp VII merged with MultiPlan in October 2020 at a $5.7 billion valuation. A Muddy Waters short report shortly after caused the stock to crater. The company rebranded to Claritev in 2024, posting $965M in 2025 revenue with $603M adjusted EBITDA. Despite carrying heavy debt from the SPAC transaction, Claritev remains operational and publicly traded, initiating a $75M share buyback in 2026.
Timeline
2020-02-12
S-1 Registration Filed
2020-09-18
Merger Proxy Filed (DEFM14A)